Indications

Independent use of Cal-Mag SAP three times daily is expected to contribute to the maintenance of bone strength and health

Ingredients

Each non-GMO vegetable capsule contains:

*Calcium citrate 110 mg
*Magnesium citrate 75 mg
VitaminD3 (cholecalciferol) 100IU
*Elemental value

Contains no: preservatives, artificial flavor or color, sugar, milk, starch, corn, wheat, yeast, citrus or egg.

Description

Bone mass and vitamin D synthesis decrease with ageing and inactivity in women and men. Reducing bone loss delays the onset of weakness, thus lowering fracture risk. Peak bone mass is determined by genetics, body weight, weight-bearing activity, and intake of nutrients composing the bone matrix and/or regulating its metabolism. Adequate calcium intake is important to prevent bone resorption and osteoporosis, and higher magnesium intakes have been positively associated with bone mineral density. Vitamin D3 is essential for maintaining calcium levels and increases calcium absorption from the intestine.

Quantity

120 capsules

Dose

1 capsule 3 times daily or as directed by your health care practitioner.
3 capsules provide 330 mg of elemental calcium, 225 mg of elemental magnesium, and 300 IU
of vitamin D3.

References

"Show references"

"Hide references"

1. Branca, F. and S. VatueÑa. “Calcium, physical activity and bone health—building bones for a stronger future”. Public Health Nutrition 4, No. 1A (2001): 117–123.
2. Nieves, J.W. “Osteoporosis: the role of micronutrients”. The American Journal of Clinical Nutrition 81, No. 5 (2005): 1232S–1239S.
3. Dietary Reference Intakes for Calcium, Phosphorous, Magnesium, Vitamin D, and Fluoride (1997); http://www.iom.edu/~/media/Files/Activity%20Files/Nutrition/DRIs/DRI_Elements.pdf
4. Dietary Reference Intakes for Calcium, Phosphorous, Magnesium, Vitamin D, and Fluoride (1997); http://www.iom.edu/~/media/Files/Activity%20Files/Nutrition/DRIs/DRI_Vitamins.pdf
5. Prentice, A. “Diet, nutrition and the prevention of osteoporosis”. Public Health Nutrition 7, No. 1A: 227–243. 6. Celotti, F. and A. Bignamini. “Dietary calcium and mineral/vitamin supplementation: a controversial problem”.
The Journal of International Medical Research 27, No. 1 (1999): 1–14.
7. Seelig, M.S. “Increased need for magnesium with the use of combined oestrogen and calcium for osteoporosis
treatment”. Magnesium Research 3, No. 3 (1990): 197–215.
8. Weaver, C.M. and R.P. Heany. “Calcium”, in Modern Nutrition in Health and Disease, Ninth Edition. Shils, M.E.,
J.A. Olson, M. Shike, and A.C. Ross, eds. Philadelphia, Pennsylvania, USA: Lippincott, Williams & Wilkins, 1999:
p. 141–155.
9. Shils, M.E. “Magnesium”, in Modern Nutrition in Health and Disease, Ninth Edition. Shils, M.E., J.A. Olson, M.
Shike, and A.C. Ross, eds. Philadelphia, Pennsylvania, USA: Lippincott, Williams & Wilkins, 1999: p. 169–192. 10. Abrams, S.A. and S.A. Atkinson. “Calcium, magnesium, phosphorus and vitamin D fortification of
complementary foods”. The Journal of Nutrition 133, No. 9 (2003): 2994S–2999S.
11. Ryder, K.M., R.I. Shorr, A.J. Bush, et al. “Magnesium intake from food and supplements is associated with
bone mineral density in healthy older white subjects”. Journal of the American Geriatrics Society 53, No. 11
(2005): 1875–1880.
12. Mackerras, D. and T. Lumley. “First- and second-year effects in trials of calcium supplementation on the loss of
bone density in postmenopausal women”. Bone 21, No. 6 (1997): 527–533.
13. Shea, B., G. Wells, A. Cranney, et al. “Meta-analyses of therapies for postmenopausal osteoporosis. VII. Meta-
analysis of calcium supplementation for the prevention of postmenopausal osteoporosis”. Endocrine Reviews
23, No. 4 (2002): 552–559.
14. McKane, W.R., S. Khosla, K.S. Egan, et al. “Role of calcium intake in modulating age-related increases in
parathyroid function and bone resorption”. The Journal of Clinical Endocrinology and Metabolism 81, No. 5 (1996): 1699–1703.